SNDX R&D Expenses
Syndax Pharmaceuticals Inc · R&D Expenses
SNDX R&D Expenses
Latest reported$261.80Mperiod ending
SNDX R&D Expenses ($6.09M → $261.80M)
Annual R&D Expenses
High-resolution chart · PNG
SNDX r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 258,784,000 | |
| 241,647,000 | |
| 163,032,000 | |
| 118,499,000 | |
| 88,248,000 | |
| 50,435,000 | |
| 42,994,000 | |
| 60,106,000 | |
| 48,201,000 | |
| 31,665,000 | |
| 9,549,000 | |
| 10,175,000 | |
| 3,208,000 | |
| 5,240,000 | |
| 6,087,000 |